Selected research
Market Structure
Global Liquid Embolic System Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Liquid Embolic System market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Liquid Embolic System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Liquid Embolic System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Liquid Embolic System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Liquid Embolic System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Liquid Embolic System include Medtronic, Terumo, Saikesaisi Holding, MicroVention, Meril Life, CERENOVUS and Balt, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Liquid Embolic System market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Liquid Embolic System and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Liquid Embolic System sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Liquid Embolic System market size, projected growth trends, production technologies, key applications, and end-use industries.
Liquid Embolic System Segment by Company
Medtronic
Terumo
Saikesaisi Holding
MicroVention
Meril Life
CERENOVUS
Balt
Liquid Embolic System Segment by Type
6% EVOH
8% EVOH
Liquid Embolic System Segment by Application
Arteriovenous Malformations
Hypervascular Tumors
Other
Liquid Embolic System Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Liquid Embolic System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Liquid Embolic System and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Liquid Embolic System.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Liquid Embolic System market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Liquid Embolic System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Liquid Embolic System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Liquid Embolic System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 6% EVOH
- 8% EVOH
Applications
- Arteriovenous Malformations
- Hypervascular Tumors
- Other
Companies covered
- Medtronic
- Terumo
- Saikesaisi Holding
- MicroVention
- Meril Life
- CERENOVUS
- Balt
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Liquid Embolic System Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Liquid Embolic System Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Liquid Embolic System Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Liquid Embolic System Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Liquid Embolic System Market Dynamics
- 2.1 Liquid Embolic System Industry Trends
- 2.2 Liquid Embolic System Industry Drivers
- 2.3 Liquid Embolic System Industry Opportunities and Challenges
- 2.4 Liquid Embolic System Industry Restraints
3 Liquid Embolic System Market by Manufacturers
- 3.1 Global Liquid Embolic System Revenue by Manufacturers (2021-2026)
- 3.2 Global Liquid Embolic System Sales by Manufacturers (2021-2026)
- 3.3 Global Liquid Embolic System Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Liquid Embolic System Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Liquid Embolic System Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Liquid Embolic System Manufacturers, Product Type & Application
- 3.7 Global Liquid Embolic System Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Liquid Embolic System Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Liquid Embolic System Players Market Share by Revenue in 2025
- 3.8.3 2025 Liquid Embolic System Tier 1, Tier 2, and Tier 3
4 Liquid Embolic System Market by Type
- 4.1 Liquid Embolic System Type Introduction
- 4.1.1 6% EVOH
- 4.1.2 8% EVOH
- 4.2 Global Liquid Embolic System Sales by Type
- 4.2.1 Global Liquid Embolic System Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Liquid Embolic System Sales by Type (2021-2032)
- 4.2.3 Global Liquid Embolic System Sales Market Share by Type (2021-2032)
- 4.3 Global Liquid Embolic System Revenue by Type
- 4.3.1 Global Liquid Embolic System Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Liquid Embolic System Revenue by Type (2021-2032)
- 4.3.3 Global Liquid Embolic System Revenue Market Share by Type (2021-2032)
5 Liquid Embolic System Market by Application
- 5.1 Liquid Embolic System Application Introduction
- 5.1.1 Arteriovenous Malformations
- 5.1.2 Hypervascular Tumors
- 5.1.3 Other
- 5.2 Global Liquid Embolic System Sales by Application
- 5.2.1 Global Liquid Embolic System Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Liquid Embolic System Sales by Application (2021-2032)
- 5.2.3 Global Liquid Embolic System Sales Market Share by Application (2021-2032)
- 5.3 Global Liquid Embolic System Revenue by Application
- 5.3.1 Global Liquid Embolic System Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Liquid Embolic System Revenue by Application (2021-2032)
- 5.3.3 Global Liquid Embolic System Revenue Market Share by Application (2021-2032)
6 Global Liquid Embolic System Sales by Region
- 6.1 Global Liquid Embolic System Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Liquid Embolic System Sales by Region (2021-2032)
- 6.2.1 Global Liquid Embolic System Sales by Region (2021-2026)
- 6.2.2 Global Liquid Embolic System Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Liquid Embolic System Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Liquid Embolic System Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Liquid Embolic System Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Liquid Embolic System Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Liquid Embolic System Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Liquid Embolic System Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Liquid Embolic System Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Liquid Embolic System Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Liquid Embolic System Revenue by Region
- 7.1 Global Liquid Embolic System Revenue by Region
- 7.1.1 Global Liquid Embolic System Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Liquid Embolic System Revenue by Region (2021-2026)
- 7.1.3 Global Liquid Embolic System Revenue by Region (2027-2032)
- 7.1.4 Global Liquid Embolic System Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Liquid Embolic System Revenue (2021-2032)
- 7.2.2 North America Liquid Embolic System Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Liquid Embolic System Revenue (2021-2032)
- 7.3.2 Europe Liquid Embolic System Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Liquid Embolic System Revenue (2021-2032)
- 7.4.2 Asia-Pacific Liquid Embolic System Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Liquid Embolic System Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Liquid Embolic System Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Medtronic
- 8.1.1 Medtronic Company Information
- 8.1.2 Medtronic Business Overview
- 8.1.3 Medtronic Liquid Embolic System Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Medtronic Liquid Embolic System Product Portfolio
- 8.1.5 Medtronic Recent Developments
- 8.2 Terumo
- 8.2.1 Terumo Company Information
- 8.2.2 Terumo Business Overview
- 8.2.3 Terumo Liquid Embolic System Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Terumo Liquid Embolic System Product Portfolio
- 8.2.5 Terumo Recent Developments
- 8.3 Saikesaisi Holding
- 8.3.1 Saikesaisi Holding Company Information
- 8.3.2 Saikesaisi Holding Business Overview
- 8.3.3 Saikesaisi Holding Liquid Embolic System Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Saikesaisi Holding Liquid Embolic System Product Portfolio
- 8.3.5 Saikesaisi Holding Recent Developments
- 8.4 MicroVention
- 8.4.1 MicroVention Company Information
- 8.4.2 MicroVention Business Overview
- 8.4.3 MicroVention Liquid Embolic System Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 MicroVention Liquid Embolic System Product Portfolio
- 8.4.5 MicroVention Recent Developments
- 8.5 Meril Life
- 8.5.1 Meril Life Company Information
- 8.5.2 Meril Life Business Overview
- 8.5.3 Meril Life Liquid Embolic System Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Meril Life Liquid Embolic System Product Portfolio
- 8.5.5 Meril Life Recent Developments
- 8.6 CERENOVUS
- 8.6.1 CERENOVUS Company Information
- 8.6.2 CERENOVUS Business Overview
- 8.6.3 CERENOVUS Liquid Embolic System Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 CERENOVUS Liquid Embolic System Product Portfolio
- 8.6.5 CERENOVUS Recent Developments
- 8.7 Balt
- 8.7.1 Balt Company Information
- 8.7.2 Balt Business Overview
- 8.7.3 Balt Liquid Embolic System Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Balt Liquid Embolic System Product Portfolio
- 8.7.5 Balt Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Liquid Embolic System Value Chain Analysis
- 9.1.1 Liquid Embolic System Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Liquid Embolic System Production Mode & Process
- 9.2 Liquid Embolic System Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Liquid Embolic System Distributors
- 9.2.3 Liquid Embolic System Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst